EPISODE · Apr 27, 2022 · 48 MIN
Aaron Michel, Founder and VC - 1984 Ventures
from Angel Invest Boston · host Sal Daher, CFA - Angel Invest Boston Podcast
The promise of angel-scale biotech: Learn More Founder & VC Aaron Michel of 1984.vc on portfolio companies, Reggora, Faimarkit and Relevize and how they exemplify the firm's approach to seed-stage investing. Aaron also gives Sal a mind-expanding suggestion on angel-scale biotech. Compelling & jargon-free! Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson Sal Daher, CFA Introduces Aaron Michel, Venture Capitalist at 1984.VC Reggora: "...they're just enabling the lenders to do an appraisal almost in an Uberized fashion, in a much faster and much more efficient way than it used to be." Brian & Will of Reggora Sold $5 Million of Real Estate in their Senior Year at Boston University A Dorm Room Business Helped the Founders of Reggora Discover a Scalable Business Opportunity Fairmarkit Is Automating the Enterprise Procurement Process Relevize – Helps Companies Sell Better via Channel Partners Relevize Gives Channel Partners Digital Advertising Content and Then Monitors Performance Aaron Michels Founded PathSource to Help People Find the Right Career Sal's Partner Bob Smith Was Not Cut Out for the Law But was a Natural Entrepreneur "Both my parents are professors. They were both professors at Boston University. Both had started companies." CareerPath's Pivot How Aaron Michel Crossed Over from Being an Operator to Being a VC "Ideally, you can choose your competitor set." "For B2B actually, we are open to investing pre-launch, as long as there's a product." Aaron Michel's Mind-Expanding Suggestion for How Better to Address the Opportunities of Angel-Scale Biotech "VCs tend to overvalue their advice and undervalue their introductions." Topics: founding story, competition, venture capital
NOW PLAYING
Aaron Michel, Founder and VC - 1984 Ventures
No transcript for this episode yet
Similar Episodes
Nov 18, 2023 ·7m
Nov 18, 2023 ·8m
Nov 18, 2023 ·8m
Nov 18, 2023 ·8m
Nov 18, 2023 ·12m
Nov 18, 2023 ·12m